AIM ImmunoTech Announces Closing of $8.0 Million Public Offering

Maxim Group LLC acted as sole placement agent in connection with this offering. The securities described above were being offered pursuant to a registration statement on Form S-1, as amended (File No. 333-284443) (the "Registration Statement"), which was declared effective by the Securities and Exchange Commission (the "SEC") on July 28, 2025. Copies of the final prospectus relating to this offering have been filed with the SEC and may be obtained from Maxim Group LLC, 300 Park Avenue, 16 Floor, New York, N ...